|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 706 JPY | -0.56% |
|
+1.15% | +24.51% |
Oncolys BioPharma Inc. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was JPY 784.51 million compared to JPY 318.32 million a year ago. Net loss was JPY 835.25 million compared to JPY 979.68 million a year ago.
Basic loss per share from continuing operations was JPY 48.2 compared to JPY 58.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +24.51% | 96.38M | |
| -3.79% | 88.14B | |
| +1.45% | 40.51B | |
| -15.94% | 31.67B | |
| +52.66% | 24.62B | |
| -14.50% | 15.65B | |
| -14.38% | 12.07B | |
| -9.12% | 11.97B | |
| -42.56% | 11.61B | |
| +4.87% | 8.81B |
ONCOLYS BIOPHARMA INC. 
